000			02103nam a2200289 4500
001			ESSALUD
005			20260817144932.0
007			ta
008			t pe ||||| |||| 00| 0 spa d
040			_aBMG
041			_aeng
100			_aCho, Hae Lin _eAutor _954080
245			_aConsumed with Inflammation. _bClinical Problem-Solving
300			_apáginas: 593-598
520			_aA 60-year-old woman with stage II triple-negative breast cancer presented to the emergency department with a weeklong history of fevers, rigors, malaise, nonproductive cough, and nausea. She reported intermittent lightheadedness, headaches, and neck pain when febrile but no sore throat, rhinorrhea, shortness of breath, vomiting, abdominal pain, or dysuria. She noted no recent travel or sick contacts. Two months before presentation, she completed neoadjuvant carboplatin, paclitaxel, and doxorubicin and then, 1 month before presentation, underwent lumpectomy of the left breast and sentinel-lymph-node biopsy. She had also been treated as part of a clinical trial with multiple cycles of pembrolizumab (first dose, 6 months before presentation; last dose, 6 days before presentation). Although she had had transient neutropenia from chemotherapy, her white-cell counts had normalized after her last cycle. Postoperatively, mild tenderness and swelling around her left axilla had developed without systemic signs of infection; computed tomographic (CT) imaging was consistent with an uncomplicated seroma. In the days leading up to this presentation, her tenderness in this area had resolved.
650			_aMEDICINA CLÍNICA HOSPITALARIA _953754
650			_aCANCER DE MAMA _954081
650			_aHEMATOLOGÍA _97422
650			_aONCOLOGÍA _912240
650			_aENFERMEDAD INFLAMATORIA _953667
700			_aBerliner, Nancy _954082
700			_aBabcock, Stephen _954083
700			_aSun, Yee-Ping _954084
700			_aLevy , Bruce _954085
773	0		_022717 _922644 _dMassachusetts NEJM Group _oNEJM009 _tThe New England Journal of Medicine _wESSALUD _x0028-4793
942			_cARTICULOS _e2026-08-17 _zSQB
999			_c22822 _d22822